Borgeson Blake

CIK 00018560941 companySALT LAKE CITY, UT

SEC Profile

Transactions

Companies

Filings

CIK

0001856094

Recent Transactions

50 trades

Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-01-06$4.36/sh−220,000→ 6,649,863 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-02$4.37/sh−220,000→ 6,869,863 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2025-06-18+44,031→ 44,031 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-06-18+22,016→ 7,089,863 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-01-02+1,734→ 7,067,847 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-11-12$7.64/sh−11,447→ 7,066,113 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-10-29$6.72/sh−11,447→ 7,077,560 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-10-15$6.67/sh−11,447→ 7,089,007 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-10-01+2,026→ 7,100,454 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-10-01$6.22/sh−11,447→ 7,098,428 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-09-17$6.84/sh−11,447→ 7,109,875 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-09-03$6.27/sh−11,447→ 7,121,322 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-08-20$7.12/sh−11,447→ 7,132,769 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-08-06$6.82/sh−11,447→ 7,144,216 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-07-23$8.48/sh−11,447→ 7,155,663 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-07-09$7.32/sh−11,447→ 7,167,110 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-07-01+1,441→ 7,178,557 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-06-25$9.51/sh−11,447→ 7,177,116 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-06-11$8.45/sh−11,447→ 7,188,563 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-06-03+26,193→ 26,193 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-06-03+13,097→ 7,200,010 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-05-28$9.17/sh−11,447→ 7,186,913 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-05-14$10.12/sh−20,054→ 7,198,360 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-04-30$7.95/sh−11,447→ 7,218,414 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-04-16$7.66/sh−11,447→ 7,229,861 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-04-02$8.82/sh−11,447→ 7,241,308 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-03-19$10.79/sh−20,054→ 7,252,755 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-03-05$12.06/sh−20,054→ 7,272,809 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-02-20$12.31/sh−19,745→ 7,293,172 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-02-20$13.04/sh−309→ 7,292,863 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-02-06$9.30/sh−11,447→ 7,312,917 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-01-23$10.58/sh−20,054→ 7,324,364 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-01-09$13.81/sh−13,751→ 7,344,418 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-01-09$13.21/sh−6,303→ 7,358,169 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-12-26$10.63/sh−20,054→ 7,364,472 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-12-12$7.40/sh−11,447→ 7,384,526 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-11-28$6.72/sh−11,447→ 7,395,973 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-11-14$6.32/sh−8,885→ 7,407,420 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-10-31$5.27/sh−8,885→ 7,416,305 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-10-17$6.58/sh−8,885→ 7,425,190 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-10-03$7.29/sh−8,885→ 7,434,075 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-09-19$8.36/sh−8,885→ 7,442,960 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-09-05$8.79/sh−8,885→ 7,451,845 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-08-22$8.91/sh−8,885→ 7,460,730 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-08-08$11.03/sh−14,498→ 7,472,887 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-08-08$11.75/sh−3,272→ 7,469,615 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-07-25$14.61/sh−18,719→ 7,487,385 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-07-11$6.89/sh−8,885→ 7,520,104 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-06-29−14,000→ 7,506,104 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-06-27$7.39/sh−8,885→ 7,528,989 total

Borgeson Blake

Recent Transactions

Companies

Recent Filings

Address